Associate Professor, Medicine-Massachusetts General Hospital, Harvard Medical School
Cardiology
Dr. Sekar Kathiresan, MD
|
|
Give Review
Sekar Kathiresan works in the field of Cardiology. He researched medicine at Harvard Medical School. Harvard Medical School is a top medical college. Harvard Medical School is ranked 1 in research and 12 in primary care medicine He received 1 awards: "Elected Member". Sekar Kathiresan is also published. He has 49 publications published. The lastest publication: "Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease.' Sekar Kathiresan, MD accepts Medicare.
Publications
- Risk prediction by genetic risk scores for Coronary heart disease is independent of self-reported family history.
- Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.
- Surprises From Genetic Analyses of Lipid Risk Factors for Atherosclerosis.
- Genome-wide identification of microRNAs regulating cholesterol and triglyceride homeostasis.
- Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci.
- Genetic risk, Coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials.
- Systematic cell-based phenotyping of missense alleles empowers rare variant association studies: a case for LDLR and Myocardial infarction.
- Genetic studies of body mass index yield new insights for obesity biology.
- Exome Sequencing in Suspected Monogenic Dyslipidemias.
- Age-related clonal hematopoiesis associated with adverse outcomes.
- Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for Myocardial infarction.
- Association of sickle cell trait with chronic kidney Disease and albuminuria in African Americans.
- Twelve-single nucleotide polymorphism genetic risk score identifies individuals at increased risk for future Atrial fibrillation and stroke.
- Association of exome sequences with plasma C-reactive protein levels in >9000 participants.
- Multiple Associated Variants Increase the Heritability Explained for Plasma Lipids and Coronary Artery Disease.
- Integrative genomics reveals novel molecular pathways and gene networks for Coronary artery disease.
- Loss-of-function mutations in SLC30A8 protect against type 2 diabetes.
- Increased Burden of Cardiovascular Disease in Carriers of APOL1 Genetic Variants.
- Association of low-frequency and rare coding-sequence variants with blood lipids and Coronary heart disease in 56,000 whites and blacks.
- Whole-Exome Sequencing Identifies Rare and Low-Frequency Coding Variants Associated with LDL Cholesterol.
- Small Dense Low-Density Lipoprotein-Cholesterol Concentrations Predict Risk for Coronary Heart Disease: The Atherosclerosis Risk in Communities (ARIC) Study.
- Genome-Wide Association Study for Circulating Tissue Plasminogen Activator Levels and Functional Follow-Up Implicates Endothelial STXBP5 and STX2.
- Searching for missing heritability: Designing rare variant association studies.
- Novel Genetic Markers Associate with Atrial Fibrillation Risk in Europeans and Japanese.
- Meta-analysis of gene-level tests for rare variant association.
- APOE p.Leu167del mutation in familial hypercholesterolemia.
- Discovery and refinement of loci associated with lipid levels.
- Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes.
- Common variants associated with plasma triglycerides and risk for Coronary artery disease.
- Exome Sequencing and Directed Clinical Phenotyping Diagnose Cholesterol Ester Storage Disease Presenting as Autosomal Recessive Hypercholesterolemia.
- Association Study of Common Genetic Variants and HIV-1 Acquisition in 6,300 Infected Cases and 7,200 Controls.
- Multiple Inflammatory Biomarkers in Relation to Cardiovascular Events and Mortality in the Community.
- Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture.
- Association of genome-wide variation with highly sensitive cardiac troponin-T levels in European americans and blacks: a meta-analysis from atherosclerosis risk in com...
- Relations of long-term and contemporary lipid levels and lipid genetic risk scores with Coronary artery calcium in the framingham heart study.
- Genome-wide association study for circulating levels of PAI-1 provides novel insights into its regulation.
- Will cholesteryl ester transfer protein inhibition succeed primarily by lowering low-density lipoprotein cholesterol?: insights from human genetics and clinical trials.
- Clinical and genetic association of serum paraoxonase and arylesterase activities with cardiovascular risk.
- Exome sequencing and complex Disease: practical aspects of rare variant association studies.
- The metabochip, a custom genotyping array for genetic studies of metabolic, cardiovascular, and anthropometric traits.
- Plasma HDL cholesterol and risk of Myocardial infarction: a mendelian randomisation study.
- Meta-analysis identifies six new susceptibility loci for Atrial fibrillation.
- Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis.
- Genetics of human cardiovascular Disease.
- Association between glucokinase regulatory protein (GCKR) and apolipoprotein A5 (APOA5) gene polymorphisms and triacylglycerol concentrations in fasting, postprandial,...
- Cardiovascular Event Prediction and Risk Reclassification by Coronary, Aortic, and Valvular Calcification in the Framingham Heart Study.
- Best Practices and Joint Calling of the HumanExome BeadChip: The CHARGE Consortium.
- Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of Coronary heart disease.
Schools
Harvard Medical School
Mass General Hospital
Procedures Preformed
- Cardiac Imaging
- Cardiac Myocardial Perfusion Imaging
- Chest CT (incl. Heart and Lungs)
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- Elected Member
Education
-
Massachusetts General Hospital -
Harvard Medical School
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1134101280 | |
| NPPES Provider LastName | KATHIRESAN | |
| NPPES Provider FirstName | SEKAR | |
| NPPES Provider ZIPCode | 02114 | |
| NPPES Provider State | MA | |
| Specialty Description | Cardiology | |
| Total Claim Count | 106.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1134101280 |
| Last Name Of The Provider | KATHIRESAN |
| First Name Of The Provider | SEKAR |
| View All |
Similar Doctors
|
|
Dr. Gregory D. Curfman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Benjamin A. Olenchock, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel A. Solomon, MD |
|
|
Dr. David P. Faxon, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Matthew P. Coggins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Neil J. Wimmer, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amer Johri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Brandon M. Jones, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Khalid S. Aljabri, MD |
|
|
Dr. Frederick L. Ruberg, MD
This Doctor is OpenDoctor Recommended.
|